Aurobindo Pharma Ltd.

NSE: AUROPHARMA | BSE: 524804 | ISIN: INE406A01037 | Industry: Pharmaceuticals
| Strong Performer, Getting Expensive
1712.0000 -4.00 (-0.23%)
NSE Sep 25, 2026 15:31 PM
Volume: 624.7K
 

logo
Aurobindo Pharma Ltd.
07 Nov 2025
1712.00
-0.23%
buy
by Axis Direct
Target: 1345 | Target met
Axis Direct
We maintain our BUY recommendation on the stock with a TP of Rs 1,345/share.
 
Number of FII/FPI investors increased from 749 to 781 in Jun 2026 qtr.
More from Aurobindo Pharma Ltd.
Recommended
Pre Monday: A big debut, and some new things to worry about
The Baseline | 25 Sep 2026, 06:00PM
Five Interesting Stocks Today - September 25, 2026
The Baseline | 25 Sep 2026, 05:03PM
A deal is called off, increasing the chance for Aurobindo Pharma to be debt free
| 15 Jul 2020